Randomised phase III trial of radical chemo/radiotherapy vs radiotherapy alone in the definitive management of localised muscle invasive TCC of the urinary bladder
Primary Sponsor
Urological Society of Australasia
Collaborating Groups
Trans Tasman Radiation Oncology Group (TROG)
Final Accrual
67
Trial Chairperson
Dr Kumar Gogna, QRI Mater Centre, QLD
Trial Contact
Kumar Gogna
Clinical Trial Registration
Related Post
10 June, 2026
Global cancer community prepares to unite for 2026 World Radiotherapy Awareness Day
LATEST NEWS: 10 June 2026 The global radiation therapy
4 June, 2026
Report showcases a year of impactful research, collaboration and consumer engagement
LATEST NEWS: 4 June 2025 TROG’s latest Annual Research